Belgium Aims To Drive Biologic Competition Through Tendering
New tendering rules in Belgium aim to improve competition between biosimilars and originators, for example by setting contract durations for tendering contracts and limiting the criteria for such contracts.
You may also be interested in...
The scheme still includes high rebate rates, but a controversial life cycle adjustment mechanism has been dropped.
The pharmaceutical legislation overhaul offers some solutions to the problem of immature applications.
The number of conditional marketing authorization non-renewals could increase.